IGC
Igc Pharma, Inc.
Clinical-stage biotechnology company focused on developing AI-driven treatments for Alzheimer's disease and related neurodegenerative disorders
CUSIP: 45408X100HealthcareUS1 holder
Total Value
$6.29M
Total Shares
1.07M
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
